Quality & complianceOfficial

Bayer to permanently withdraw Verquvo 2.5 mg tablets from Danish market

🇩🇰 DKMA · Fri 20 Nov 2026

The Danish Medicines Agency says marketing of vericiguat 2.5 mg film-coated tablets by Bayer A/S will end for commercial reasons, from the end of September 2026.

The Danish Medicines Agency (DKMA) has listed Verquvo 2.5 mg film-coated tablets in its supply notifications. Bayer A/S will stop marketing the product in Denmark.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: DKMA ↗

Article written by VigiEye from the official source (DKMA). AI-assisted; check the source before acting.